ReviewFrontiers in immunology2021
Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy.
Hager Mohamed et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
43 papers cite it
this paperpooled itcites it
ReviewFrontiers in immunology2021
Hager Mohamed et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.